Atrial Fibrillation Paroxysmal Clinical Trial
Official title:
Outcomes of High Power Application in Catheter Ablation of Paroxysmal Atrial Fibrillation Guided by Unipolar Signal Modification.
Pulmonary vein isolation (PVI) is the cornerstone of catheter ablation procedures in patients with paroxysmal atrial fibrillation (PAF) [1]. However, the incidence of atrial fibrillation (AF) recurrence remains high [2], mostly due to pulmonary vein (PV) reconnection [1], emphasizing the formation of transmural lesions to achieve complete conduction block along the ablation lines [3]. Previous studies have shown that elimination of the negative component of the unipolar electrogram (UP-EGM) during radiofrequency applications reflects transmural lesions. The persistence of such a negative component consistently corresponds to non-trans mural lesions [4].
Pulmonary vein isolation (PVI) is the cornerstone of catheter ablation procedures in patients with paroxysmal atrial fibrillation (PAF) [1]. However, the incidence of atrial fibrillation (AF) recurrence remains high [2], mostly due to pulmonary vein (PV) reconnection [1], emphasizing the formation of transmural lesions to achieve complete conduction block along the ablation lines [3]. Previous studies have shown that elimination of the negative component of the unipolar electrogram (UP-EGM) during radiofrequency applications reflects transmural lesions. The persistence of such a negative component consistently corresponds to non-trans mural lesions [4]. The high-power short duration (HPSD) RF application applies to all RF energies delivered at more than 40 W [5]. Higher the power more is the resistive heating causing wider tissue injury [5]. The lesion size with HPSD is larger in width but lesser in depth compared to lower powers with longer duration [5]. In contrast, RF applications of lower power and longer duration result in larger dissipation of RF energies deep into the tissues due to conductive heating causing tissue destruction at greater depths [6]. Hence, there is a risk of collateral tissue damage [5]. HPSD ablation has been advocated as a means to minimize the risk of collateral organ damage as the lesions are smaller in depth. However, Maintaining a high power for a constant duration in the absence of a guide may not be the right strategy [5]. Unipolar waveform modification by complete elimination of the negative component may serve as a guide for HPSD ablation [5]. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06085014 -
Clinical and Electrophysiological Predictors of Arrhythmic Recurrence in Patients With Paroxysmal AF Undergoing First Ablation Procedure of AF by Pulmonary Vein Isolation
|
||
| Recruiting |
NCT03724383 -
Atrial Fibrillation Lifestyle Project
|
N/A | |
| Active, not recruiting |
NCT04544397 -
Outcomes of Second Generation Laser Balloon Ablation for Atrial Fibrillation
|
||
| Not yet recruiting |
NCT05940597 -
Pulsed Field Ablation vs Cryoablation In Paroxysmal Atrial Fibrillation
|
N/A | |
| Recruiting |
NCT05251545 -
Randomized Trial: High Power Short Duration Versus Ablation Index
|
N/A | |
| Recruiting |
NCT05883631 -
RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy.
|
N/A | |
| Not yet recruiting |
NCT04600713 -
Physiotherapist-led Exercise Within Cardiac Rehabilitation and Paroxysmal Atrial Fibrillation and COVID-19.
|
N/A | |
| Enrolling by invitation |
NCT05725187 -
Prospective Validation Study of AI-based Prediction Algorithm for the Prediction of Paroxysmal Atrial Fibrillation
|
||
| Recruiting |
NCT04606693 -
Value of Screening and Treatment of SAHS in the Management of AF Ablation Candidates
|
N/A | |
| Recruiting |
NCT05328882 -
Early Recurrences of Atrial Arrhythmias and Their Impact on Late Recurrence After Pulmonary Vein Isolation With Pulsed Field Ablation of Paroxysmal Atrial Fibrillation
|
||
| Recruiting |
NCT04342312 -
Intensive Molecular and Electropathological Characterization of Patients Undergoing Atrial Fibrillation Ablation
|
||
| Recruiting |
NCT05549752 -
Flecainide Versus Amiodarone in the Cardioversion of Paroxysmal Atrial Fibrillation at the Emergency Department, in Patients With Coronary Artery Disease Without Residual Ischemia
|
Phase 3 | |
| Completed |
NCT03323099 -
Individualized Studies of Triggers of Paroxysmal Atrial Fibrillation
|
N/A | |
| Completed |
NCT05461859 -
Cardioneuroablation for the Treatment of Vagally-mediated Atrial Fibrillation.
|
||
| Enrolling by invitation |
NCT04634461 -
The Relationship Between Panic Attack Symptoms and Atrial Fibrillation Episodes.
|
||
| Completed |
NCT04023461 -
Isolation of Pulmonary Veins With PVAC GOLD in Elderly Patients
|
Phase 4 | |
| Recruiting |
NCT06392932 -
Esophageal Temperature During PVI Using Q-DOT Micro
|
N/A | |
| Not yet recruiting |
NCT06364215 -
Posterior Wall Substrate Modification Using Irreversible Electroporation for Paroxysmal Atrial Fibrillation
|
N/A | |
| Recruiting |
NCT05292209 -
RiLuzole to Reduce Atrial FIb Study Using Holter Monitoring
|
Phase 2 | |
| Completed |
NCT04511520 -
Efficacy of Personalized Exercise Program and Trimetazidine in Rehabilitation of Patients After RFA of AF
|
N/A |